
1 

(1) These Regulations may be cited as the National Health Service (General Medical and Pharmaceutical Services) Amendment (No. 4) Regulations 1987 and shall come into force on 1st September 1987.
(2) In these Regulations—
(a) “the principal Regulations” means the National Health Service (General Medical and Pharmaceutical Services) Regulations 1974; and
(b) “the 1987 (No. 2) Regulations” means the National Health Service (General Medical and Pharmaceutical Services) Amendment (No. 2) Regulations 1987.
2 

(1) The principal Regulations are amended in accordance with paragraphs (2) to (6) of this regulation.
(2) In regulation 29 (schemes for securing proper pharmaceutical services)—
(a) in paragraph (4), after “a scheme” there is inserted “prepared under paragraph (1)(a)”;
(b) the paragraph (5) added by regulation 2(5)(b) of the 1987 (No. 2) Regulations is renumbered “(4A)”.
(3) In Schedule 1 (terms of service for doctors), in paragraph 36A(2)(b), for “treatment of the condition” there is substituted “purpose”.
(4) In Schedule 3A (drugs and other substances not to be prescribed for supply under pharmaceutical services)—
(a) the following entries are omitted:—
 Dynese Plus Aqueous Suspension
 Haymine Tablets
 Kolanticon Gel
 Polycrol Forte Tablets
 Polycrol Gel
 Polycrol Tablets
 Pregnavite Forte F Tablets;
(b) the following entries are inserted at the appropriate point in the alphabetical order:—
 Fiberform
 Octovit Tablets.
(5) For Schedule 3B (drugs to be prescribed under pharmaceutical services only in certain circumstances) there is substituted the Schedule 3B set out in the Schedule to these Regulations.
(6) In Schedule 4C (provisions further to regulation 26—pharmaceutical lists)—
(a) in Part II (pharmacy practices sub-committee), in paragraph 6(2), after “sub-paragraph (1)(b)” there is inserted “or (c)”; and
(b) in Part IV (appeals), in paragraph 13(2)(c)(iii), for “paragraph (1)(d)” there is substituted “paragraph 1(1)(d)”.
(7) In regulation 2(5)(a) of the 1987 (No. 2) Regulations, the words “each of” and “and paragraph (4)” are omitted.
3 
Regulation 3 of, and Schedule 3 to, the National Health Service (General Medical and Pharmaceutical Services) Amendment (No. 6) Regulations 1985 are revoked.
Signed by authority of the Secretary of State for Social Services.
Tony Newton
Minister of State,
Department of Health and Social Security
6th August 1987
SCHEDULE
Regulation 2(5)

SCHEDULE 3B
Regulation 2(1)


Column 1 Column 2 Column 3
Drug Patient Purpose
Acetylcysteine Granules Any patient Treatment of abdominal complications associated with cystic fibrosis
Carbocisteine A patient under the age of 18 who has undergone a tracheostomy Treatment of any condition which, through damage or disease, affects the airways and has required a tracheostomy
Clobazam Any patient Treatment of epilepsy
Pregnavite Forte F Tablets A woman who has previously given birth to a child (whether or not born alive) with a defect of the neural tube or aborted a foetus with such a defect Reduction of the risk of spina bifida or anencephaly in a child which may be born to the patient